The current state and future perspectives of cannabinoids in cancer biology

Abstract

To date, cannabinoids have been allowed in the palliative medicine due to their analgesic and antiemetic effects, but increasing number of preclinical studies indicates their anticancer properties. Cannabinoids exhibit their action by a modulation of the signaling pathways crucial in the control of cell proliferation and survival. Many in vitro and in vivo experiments have shown that cannabinoids inhibit proliferation of cancer cells, stimulate autophagy and apoptosis, and have also a potential to inhibit angiogenesis and metastasis. In this review, we present an actual state of knowledge regarding molecular mechanisms of cannabinoids' anticancer action, but we discuss also aspects that are still not fully understood such as the role of the endocannabinoid system in a carcinogenesis, the impact of cannabinoids on the immune system in the context of cancer development, or the cases of a stimulation of cancer cells' proliferation by cannabinoids. The review includes also a summary of currently ongoing clinical trials evaluating the safety and efficacy of cannabinoids as anticancer agents.

Preclinical studies have shown that cannabinoids can exhibit anticancer action, but the role of the endocannabinoid system in carcinogenesis is not fully elucidated. There are also cases of stimulation of cancer cells' proliferation by cannabinoids. We present an actual state of knowledge regarding mechanisms of cannabinoids' impact on cancer cells.

http://ift.tt/2HCY23w